Overview
Effects of Aliskiren/Amlodipine Versus Amlodipine Monotherapy on Ankle-foot Volume in Hypertensive Patients
Status:
Unknown status
Unknown status
Trial end date:
2010-03-01
2010-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Comparison between the effect of aliskiren/amlodipine combination with amlodipine monotherapy on ankle-foot volume in hypertensive patients. It will be enrolled male or female outpatients, aged 18-65 years.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
University of PaviaTreatments:
Amlodipine
Criteria
Inclusion Criteria:- diastolic blood pressure > 95 mmHg and < 110 mmHg
- systolic blood pressure > 140 mmHg and < 180 mmHg
- no amlodipine therapy for the previous 6 months
Exclusion Criteria:
- diastolic blood pressure > 110 mmHg and or
- systolic blood pressure > 180 mmHg
- secondary hypertension
- heart failure
- diabetes mellitus
- liver or kidney diseases